Uterine Myoma, Ovary Neoplasm, Adenomyosis Clinical Trial
Official title:
A Randomized Prospective Study of Scheduled Intravenous Ramosetron for the Prevention of Nausea and Vomiting in Hospitalized Patients After Gynecologic Laparoscopy
To compare postoperative nausea and vomiting (PONV) and perioperative outcomes of
gynecologic patients undergoing laparoscopic surgery after scheduled administration of
intravenous Ramosetron during hospital stays.
- Randomized controlled arm : Placebo versus Ramosetron injection
- Administration schedule : immediate postoperative status, 12 hrs after surgery, 36hrs
after surgery
Surgical outcomes including operative time, blood loss, Hb change, postoperative pain, nausea/vomiting scale, times of rescue therapy, and complications ;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment